Using retinal scans to identify and monitor traumatic brain injuries.
TBI Identification and Monitoring Through Retinal Scanning
This study is testing a handy device that uses retinal scans to help detect problems caused by traumatic brain injuries, making it easier for patients and doctors to understand and track recovery, especially for those mild cases that can be hard to spot.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rebiscan, LLC NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10593933 on NIH RePORTER |
What this research studies
This research focuses on developing a portable device that utilizes retinal scanning technology to detect functional impairments caused by traumatic brain injuries (TBI). The device measures disruptions in the signals between the retina and the brain's visual pathway, providing a novel method for assessing injury at the time it occurs and throughout recovery. By combining retinal scans with existing blood-based biomarkers, the goal is to create a comprehensive assessment tool for both patients and healthcare providers. This approach aims to address the challenges in accurately diagnosing and monitoring TBI, particularly for mild cases that often go undetected.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have experienced a traumatic brain injury, particularly those with mild cases.
Not a fit: Patients with severe brain injuries or those who do not have access to the retinal scanning technology may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and monitoring of traumatic brain injuries, enhancing recovery outcomes for patients.
How similar studies have performed: While the approach of using retinal scans for TBI assessment is innovative, similar technologies have shown promise in other areas of neurological assessment, indicating potential for success.
Where this research is happening
Boston, United States
- Rebiscan, LLC — Boston, United States (Active)
Researchers
- Principal investigator: Shaka, Justin — Rebiscan, LLC
- Study coordinator: Shaka, Justin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.